FOCUS TECHNOLOGIES

Mark For: FOCUS TECHNOLOGIES® trademark registration is intended to cover the category of medical diagnostic kits comprised of diagnostic reagents for clinical and medical laboratory use. [all]

Status

2022-09-03 UTC
⟳ Refresh

DEAD REGISTRATION Cancelled Invalidated

Research	OneLook Acronym Finder
Serial Number	76239639
Registration Number	2816040
Mark Literal Elements	FOCUS TECHNOLOGIES
Mark Drawing Type	1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark Type	TRADEMARK. SERVICE MARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	SCANNING ON DEMAND 2007-06-07
Basis	1(a)
Class Status	SECTION 8 - CANCEL
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	Yes
Intent To Use	No
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Cancellation Code	2
Attorney Name	Gloria C. Phares
Attorney Docket Number	F5419-004
Law Office Assigned	M60
Employee Name	HICKEY, TONI Y

Timeline

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: Medical diagnostic kits comprised of diagnostic reagents for clinical and medical laboratory use. FIRST USE: 20010411. FIRST USE IN COMMERCE: 20010411(CANCELLED)
IC 042. US 100 101. G & S: Scientific and medical research and study relating to the surveillance of antimicrobial resistance, epidemiology and emerging infections; providing a database featuring test results that show the incidence of antimicrobial resistance in humans; clinical trial site support services, in the nature of designing, coordinating and performing clinical studies of antimicrobial resistance, epidemiology, and emerging infections; strategic consulting for rare and emerging infectious diseases. FIRST USE: 20010411. FIRST USE IN COMMERCE: 20010411